Nancy Thornberry, Director, on September 02, 2026, sold 11,439 shares in Denali Therapeutics (DNLI) for $261,929. Following the Form 4 filing with the SEC, Thornberry has control over a total of 19,686 common shares of the company, with 19,686 shares held directly.
SEC Filing: